- Detection of tumor antigens and tumor-antigen specific T cells in NSCLC patients: Correlation of the quality of T cell responses with NSCLC subtype2020 | 1. lékařská fakulta, 2. lékařská fakulta
- Case-Control Study: Smoking History Affects the Production of Tumor Antigen-Specific Antibodies NY-ESO-1 in Patients with Lung Cancer in Comparison with Cancer Disease-Free Group2017 | 1. lékařská fakulta, 2. lékařská fakulta
- Novel tumor antigens elicit anti-tumor humoral immune reactions in a subset of patients with polycythemia vera2007 | 1. lékařská fakulta
- Novel tumor antigens elicit anti-tumor humoral immune reactions in a subset of patients with polycythemia vera2007 | Fakulta tělesné výchovy a sportu
- The cellular nuclear matrix regulatory protein YY1 does not directly interact with the mouse polyomavirus large tumor antigen.2001 | Přírodovědecká fakulta
- The cellular nuclear matrix regulatory protein YY1 does not directly interact with the mouse polyomavirus large tumor antigen.2001 | 1. lékařská fakulta, Matematicko-fyzikální fakulta
- The preparation of multivalent peptide and glycopeptide dendrimers bearing Tn tumor antigen2001 | Přírodovědecká fakulta
- Multiple antigen glycopeptides (MAGs) with tumor antigens and incorporated adjuvant: Synthesis and immunobiological activities2002 | Přírodovědecká fakulta
- Multiple antigen glycopeptides (MAGs) with tumor antigens and incorporated adjuvant: Synthesis and immunobiological activities2002 | 1. lékařská fakulta, Matematicko-fyzikální fakulta
- Generation of functional dendritic cells for potential use in the treatment of acute lymphoblastic leukemia2002 | 2. lékařská fakulta
- Expression of tumor antigens on primary ovarian cancer cells compared to established ovarian cancer cell lines2016 | 2. lékařská fakulta
- Studium imunologických metod ve vztahu k energetickému metabolismu nádorového onemocnění buněk IPublikace bez příslušnosti k fakultě
- Význam krčních lymfatických uzlin v kancerogenezi a dalším šíření nádoru2012 | Lékařská fakulta v Hradci Králové
- High hydrostatic pressure affects antigenic pool in tumor cells: Implication for dendritic cell-based cancer immunotherapy2017 | 2. lékařská fakulta
- Mitochondrial Dysfunction2009 | 1. lékařská fakulta, 3. lékařská fakulta
- Generation of dendritic cell-based vaccine using high hydrostatic pressure for non-small cell lung cancer immunotherapy2017 | 1. lékařská fakulta, 2. lékařská fakulta
- In vitro assessment of dendritic cells pulsed with apoptotic tumor cells as a vaccine for ovarian cancer patients2007 | 2. lékařská fakulta
- Humoral immune response to keyhole limpet haemocyanin, the protein carrier in cancer vaccines2011 | 1. lékařská fakulta
- Relevance of the chaperone-like protein calreticulin for the biological behavior and clinical outcome of cancer2018 | Lékařská fakulta v Hradci Králové, 2. lékařská fakulta
- Inhibitor of apoptosis protein (IAP) antagonists demonstrate divergent immunomodulatory properties in human immune subsets with implications for combination therapy2013 | 2. lékařská fakulta
- Emerging glyco-based strategies to steer immune responses2021 | Přírodovědecká fakulta
- Human Tumor Cells Killed by Anthracyclines Induce a Tumor-Specific Immune Response2011 | 1. lékařská fakulta, 2. lékařská fakulta, Fakulta tělesné výchovy a sportu
- Dendritic cells pulsed with tumor cells killed by high hydrostatic pressure induce strong immune responses and display therapeutic effects both in murine TC-1 and TRAMP-C2 tumors when combined with docetaxel chemotherapy2016 | 2. lékařská fakulta
- Severe, but not mild heat-shock treatment induces immunogenic cell death in cancer cells2017 | 2. lékařská fakulta
- Distinctive germline expression of class i human leukocyte antigen (HLA) alleles and DRB1 heterozygosis predict the outcome of patients with non-small cell lung cancer receiving PD-1/PD-L1 immune checkpoint blockade2020 | 2. lékařská fakulta
- Safety and efficacy of dendritic cell-based immunotherapy DCVAC/OvCa added to first-line chemotherapy (carboplatin plus paclitaxel) for epithelial ovarian cancer: a phase 2, open-label, multicenter, randomized trial2022 | 1. lékařská fakulta, 3. lékařská fakulta, 2. lékařská fakulta, Ústřední knihovna, Lékařská fakulta v Plzni